+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pituitary relapse of acute promyelocytic leukemia after ATRA



Pituitary relapse of acute promyelocytic leukemia after ATRA



International Journal of Hematology 68(1): 101-102




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 032830794

Download citation: RISBibTeXText

PMID: 9713174


Related references

CNS relapse in a low risk acute promyelocytic leukemia patient treated with ATRA-based regimen: is there a role for prophylactic CNS therapy in acute promyelocytic leukemia?. Indian Journal of Hematology and Blood Transfusion 25(3): 118-119, 2009

Management of acute promyelocytic leukemia relapse in the ATRA era. Haematologica 83(8): 714-717, 1998

Double extramedullary relapse in acute promyelocytic leukemia following treatment with ATRA and chemotherapy. Blood 88(10 Suppl. 1 Part 1-2): 169B, 1996

Sustained remission achieved with ATRA and chemotherapy in second relapse of acute promyelocytic leukemia in Down syndrome. Journal of Pediatric Hematology/Oncology 31(8): 539-540, 2009

Central nervous system involvement at second relapse in acute promyelocytic leukemia treated with ATRA and chemotherapy. Leukemia Research 34(10): E264-E265, 2010

Extramedullary relapse following allogeneic stem cell transplantation in acute promyelocytic leukemia: the role of ATRA. Haematologica 86(10): E31, 2001

Efficacy of prolonged therapy with combined arsenic trioxide and ATRA for relapse of acute promyelocytic leukemia. Haematologica 96(9): 1390-1391, 2011

Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia. Annals of Hematology 78(7): 329-332, 1999

In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia. Leukemia 8(Suppl. 2): S16-S19, 1994

Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy. American Journal of Hematology 90(9): E181-E182, 2015

Acute promyelocytic leukemia: All-trans retinoic acid (ATRA) along with chemotherapy is superior to ATRA alone. American Journal of Hematology 60(2): 87-93, 1999

Effect of curcumin combined with ATRA on differentiation of ATRA-resistant acute promyelocytic leukemia cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 21(4): 895-898, 2013

Pharmacokinetic study of ATRA and the intermittent and cyclic regimen with ATRA and chemotherapy in pediatric acute promyelocytic leukemia. Blood 90(10 Suppl. 1 Part 2): 245B, 1997